BREAKING
AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 11 hours ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 2 days ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 2 days ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 2 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 5 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 6 days ago Synopsys Q1 2026 Earnings Results 6 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 6 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 6 days ago AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 11 hours ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 2 days ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 2 days ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 2 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 5 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 6 days ago Synopsys Q1 2026 Earnings Results 6 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 6 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 6 days ago
ADVERTISEMENT
AlphaGraphs

Earnings: A snapshot of Thermo Fisher Scientific’s (TMO) Q2 2025 report

Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in life sciences, on Wednesday announced financial results for the second quarter of fiscal 2025, reporting an increase in revenues and a modest decline in adjusted earnings. Revenues increased 3% to $10.85 billion in Q2 from $10.54 billion in the comparable quarter of 2024. The growth […]

$TMO July 23, 2025 1 min read
NYSE
$TMO · Earnings

Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in life sciences, on Wednesday announced financial results for the second quarter of fiscal 2025, reporting an increase in revenues and a modest decline in adjusted earnings. Revenues increased 3% to $10.85 billion in Q2 from $10.54 billion in the comparable quarter of 2024. The growth […]

· July 23, 2025

Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in life sciences, on Wednesday announced financial results for the second quarter of fiscal 2025, reporting an increase in revenues and a modest decline in adjusted earnings.

Revenues increased 3% to $10.85 billion in Q2 from $10.54 billion in the comparable quarter of 2024. The growth mainly reflects revenue growth in the Life Sciences and Laboratory Products segments.

Thermo Fisher Q2 2025 Earnings

Second-quarter earnings, on an adjusted basis, edged down to $5.36 per share from $5.37 per share in the year-ago quarter. Net income, on a reported basis, rose to $1.62 billion or $4.28 per share in the June quarter from $1.55 billion or $4.04 per share a year earlier.

“Our exceptional team continues to execute at a high level, enabling customer success while navigating the macroenvironment. The agility of our organization, powered by the PPI Business System, allowed us to effectively adapt to current market conditions, actively manage our cost base, and deliver strong operational results in the second quarter,” said Marc Casper, chief executive officer of Thermo Fisher Scientific.

ADVERTISEMENT

Prior Performance

  • Thermo-Fisher Q1 2025 earnings infographic

ADVERTISEMENT